Showing results (581-590 of 661) with videos related to
Sort By:
Pageof 67
Nature Cancer|May 19, 2022
Acute lymphoblastic leukemia displays a distinct highly methylated genomeSara Hetzel, Alexandra L Mattei, Helene Kretzmer, et al.Nature Cancer|January 2, 2026
Tumor ecosystem and microbiome features associated with efficacy and resistance to avelumab plus chemoradiotherapy in head and neck cancerNadeem Riaz, Tyler J Alban, Robert I Haddad, et al.Nature Cancer|April 3, 2026
PRET is a few-shot system for pan-cancer recognition without example trainingYi Li, Ziyu Ning, Tianqi Xiang, et al.Nature Cancer|June 3, 2026
Tumor transcriptional state predicts survival in immune-checkpoint-blockade-treated glioblastomaJack Y Ghannam, Julian Bryan, Jakob Weiss, et al.Nature Cancer|May 19, 2026
Targeting cysteinyl leukotriene receptor 1 reprograms tumor-promoting myelopoiesis and overcomes immune checkpoint therapy resistanceHui Tang, Ping Xie, Jihae Ahn, et al.Nature Cancer|January 30, 2024
Targeted activation of ferroptosis in colorectal cancer via LGR4 targeting overcomes acquired drug resistanceHao Zheng, Jinming Liu, Qi Cheng, et al.Nature Cancer|May 7, 2026
A high-MAPK, low-WNT cell state drives metastatic dissemination in colorectal cancerMelanie Heinlein, Ginny X Li, Noelyn Kljavin, et al.Nature Cancer|April 15, 2026
Predictive value of early PSMA upregulation for the response to enzalutamide ± 177Lu-PSMA-617 in poor-risk, metastatic, castration-resistant prostate cancer: substudy of the randomized, phase 2 ENZA-p trialLouise Emmett, Mina Swiha, Nathan Papa, et al.Nature Cancer|May 15, 2026
Combined ctDNA and serum PSA for dynamic monitoring of metastatic prostate cancer starting first-line treatment: a prospective national cohort studyAnuradha Jayaram, Memuna Rashid, Alison H M Reid, et al.Nature Cancer|March 11, 2026
Impact of using artificial intelligence as a second reader in breast screening including arbitrationLucy M Warren, Jenny Venton, Kenneth C Young, et al.Pageof 67